Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fed Conditions

NCT01659918 is registered in ClinicalTrials.gov with Roxane Laboratories as lead sponsor.

NCT NCT01659918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01659918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fed Conditions
Lead sponsor
Roxane Laboratories
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
February 29, 2008
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma